62 - Once-Weekly Semaglutide Reduces HbA1c and Body Weight Across Baseline HbA1c Subgroups in the SUSTAIN 1–5 and 7–10 Clinical Trials
- Resource Type
- Abstract
- Source
- In
Canadian Journal of Diabetes October 2020 44(7) Supplement:S26-S27 - Subject
- Language
- ISSN
- 1499-2671